A Study of the Donor Screening Experience and the Outcomes from Fecal Transplant in Patients with C. Difficile Infection

Overview

About this study

The purpose of this study is to evaluate clinical experience with donor screening for fecal transplant, and to evaluate the outcomes from fecal transplant and understand risk factors for fecal transplant failure and relapse after fecal transplant.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria

  • Group 1,  Healthy individuals who have been screened as stool donors
  • Group 2,  Patients who have received fecal transplantation for C. difficile infection

Exclusion Criteria 

  • Pediatric patients 
  • Healthy individuals who have not been screened as stool donors 
  • Patients who have not undergone fecal transplant

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Sahil Khanna, M.B.B.S.

Closed for enrollment

Contact information:

Robert Orenstein D.O.

(480)342-0115

Orenstein.Robert@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Sahil Khanna, M.B.B.S.

Open for enrollment

Contact information:

Patricia Kammer CCRP

(507)538-1827

Kammer.Patricia@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20308690

Mayo Clinic Footer